Our current study supported the antidiabetic role of miR-17, because DEHP-induced glucose intolerance, Akt inactivation, and mGlut4 attenuation were abolished when miR-17 was overexpressed in SkM by AAV-miR-17. This evidence concerns the gene AKT1 and Glucose intolerance.